Skip to content
Home/Companies/MedTech/Symcel

Symcel

MedTech·Sweden·Active·13yr hold
Entry
2013
Hold
13yr
Status
Active

Who owns Symcel?

Symcel is a Swedish MedTech company, currently owned by Flerie since 2013.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Flerie
Investor
Flerie
Flerie Invest · 2011 · Life Sciences VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from Flerie Invest

Other portfolio companies in the same fund.

Frontier Biosolutions
Active
PharmaGermany· 2023
Mendus
Active
BiotechSweden· 2023
A3P Biomedical
Exited 2025
BiotechSweden· 2022
Alder Therapeutics
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2022
Bohus Biotech
Active
PharmaSweden· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Symcel?

Symcel is currently owned by Flerie, through Flerie Invest, since 2013.

When did Flerie acquire Symcel?

Flerie acquired Symcel in 2013.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue